Cargando…

Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases

A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, especially by the marine Calcareous sponges Leucetta and Clathrina. The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article. The origin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loaëc, Nadège, Attanasio, Eletta, Villiers, Benoît, Durieu, Emilie, Tahtouh, Tania, Cam, Morgane, Davis, Rohan A., Alencar, Aline, Roué, Mélanie, Bourguet-Kondracki, Marie-Lise, Proksch, Peter, Limanton, Emmanuelle, Guiheneuf, Solène, Carreaux, François, Bazureau, Jean-Pierre, Klautau, Michelle, Meijer, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666424/ https://www.ncbi.nlm.nih.gov/pubmed/29039762 http://dx.doi.org/10.3390/md15100316

Ejemplares similares

Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A
por: Bourahla, Khadidja, et al.
Publicado: (2021)

Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A
por: Nguyen, Thu Lan, et al.
Publicado: (2018)

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice
por: Souchet, Benoît, et al.
Publicado: (2019)

SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023)

Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors
por: Schmitt, Christian, et al.
Publicado: (2014)

Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core
por: Ţînţaş, Mihaela-Liliana, et al.
Publicado: (2022)

Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer
por: Corr, Bradley R, et al.
Publicado: (2023)

Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006)

CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Geoghegan, Vincent, et al.
Publicado: (2022)

Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design
por: Meine, Rosanna, et al.
Publicado: (2018)

[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
por: Lechner, Christian, et al.
Publicado: (2019)

Novel Adociaquinone Derivatives from the Indonesian Sponge Xestospongia sp.
por: He, Fei, et al.
Publicado: (2015)

A Practical Approach to New (5Z) 2-Alkylthio-5-arylmethylene-1-methyl-1,5-dihydro-4H-imidazol-4-one Derivatives
por: Bourahla, Khadidja, et al.
Publicado: (2011)

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I
por: Foucourt, Alicia, et al.
Publicado: (2014)

Bioactive Indole Derivatives from the South Pacific Marine Sponges Rhopaloeides odorabile and Hyrtios sp.
por: Longeon, Arlette, et al.
Publicado: (2011)

Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment
por: Zu, Mian, et al.
Publicado: (2015)

Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
por: Saldivia, Manuel, et al.
Publicado: (2020)

A Collection of Bioactive Nitrogen-Containing Molecules from the Marine Sponge Acanthostrongylophora ingens
por: Esposito, Germana, et al.
Publicado: (2019)

Pharmacophore and 3D-QSAR Characterization of 6-Arylquinazolin-4-amines as Cdc2-like Kinase 4 (Clk4) and Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (Dyrk1A) Inhibitors
por: Pan, Yongmei, et al.
Publicado: (2013)

Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
por: Zhou, Qingxin, et al.
Publicado: (2020)

Editorial: Peptide/Polyketide Molecules From Marine Macro and/or Microorganisms
por: Costantino, Valeria, et al.
Publicado: (2020)

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
por: Myrianthopoulos, Vassilios, et al.
Publicado: (2012)

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
por: Fedorov, Oleg, et al.
Publicado: (2011)

Benzobisthiazoles Represent a Novel Scaffold for Kinase Inhibitors of CLK Family Members
por: Prak, Krisna, et al.
Publicado: (2015)

CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker
por: Lin, Jiarui, et al.
Publicado: (2022)

Microwave-Assisted Condensation Reactions of Acetophenone Derivatives and Activated Methylene Compounds with Aldehydes Catalyzed by Boric Acid under Solvent-Free Conditions
por: Brun, Elodie, et al.
Publicado: (2015)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

10-Iodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
por: Falke, Hannes, et al.
Publicado: (2015)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation
por: Bullock, Alex N., et al.
Publicado: (2009)

Circadian Rhythms in Visual Responsiveness in the Behaviorally Arrhythmic Drosophila Clock Mutant Clk(Jrk)
por: Nippe, Olivia M., et al.
Publicado: (2017)

CLK2 blockade modulates alternative splicing compromising MYC‐driven breast tumors
por: Salvador, Fernando, et al.
Publicado: (2018)

A single biochemical activity underlies the pleiotropy of the aging-related protein CLK-1
por: Liu, Ju-Ling, et al.
Publicado: (2017)

Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors
por: Murai, Aiko, et al.
Publicado: (2020)

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
por: Dao, Viet Hung, et al.
Publicado: (2021)

Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency
por: Dahal, Subha, et al.
Publicado: (2022)

Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2
por: Bulos, Maya L., et al.
Publicado: (2023)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
por: ElHady, Ahmed K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_simt0fqku7bkmdj9mla1nocd3i